Featured Image
Why is it important?
Our findings show that the amount of this protein in tumours, predicts survival responses of ovarian cancer patients.
Perspectives
The aim is for people to better appreciate that there are molecules that can independently predict survival outcomes in ovarian cancer. We are still unclear how the production of this protein interacts with the cancer cell and this is the subject of ongoing work...
Dr Lee Machado
University of Northampton
Read the Original
This page is a summary of: High mobility group protein B1 is a predictor of poor survival in ovarian cancer, Oncotarget, August 2017, Impact Journals, LLC,
DOI: 10.18632/oncotarget.20538.
You can read the full text:
Contributors
The following have contributed to this page
